Cargando…
hPG(80) (circulating progastrin) as a blood biomarker for high-grade glial tumors: A pilot study
BACKGROUND: Currently, the long-term prognosis and survival rate of patients with high-grade glial tumors remains poor and there are no biomarkers. hPG(80) (circulating progastrin) secreted into the blood by tumor cells has been widely studied in colorectal cancer. Its involvement in tumorigenesis h...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874683/ https://www.ncbi.nlm.nih.gov/pubmed/36712425 http://dx.doi.org/10.3389/fneur.2022.1073476 |